Footprinting experiments for DNase I digests of a 139-base-pair segment of pBR-322 DNA in the presence of either netropsin or actinomycin D were carried out. Plots of oligonucleotide concentration as a function of drug concentration were analyzed to study the enhancement in cleavage rates at '30 sites, accompanying drug binding at other sites. The pattern of enhancements is not consistent with drug-induced DNA structural changes, but agrees with a redistribution mechanism involving DNase I. Since the total number of enzyme molecules per fragment remains unchanged, drug binding at some sites increases the enzyme concentration at other sites, giving rise to increased cleavage. The consequences of the redistribution mechanism for analysis of footprinting experiments are indicated.
INTRODUCTION
Footprinting analysis provides a means of identifying the binding sites of equilibrium binding drugs and proteins on DNA molecules derived from natural sources (1) (2) (3) (4) (5) . The most frequently used probe in footprinting studies is the endonuclease DNase I. The enzyme not only reports the sites of ligand binding but, since it is sensitive to local changes in DNA structure, it has also been used to determine the sites of ligand-induced structural changes in DNA. These are reflected in enhancements in the DNase I cleavage rate, appearing as sites on the DNA lattice bind ligand (6) (7) (8) (9) (10) .
The rate of cleavage by DNase I at a phosphodiester linkage of DNA, (rate)i, is governed by rate expression (1) , where ki is the cleavage rate constant at the site and [DNaseI] i is the concentration of enzyme at the (rate)i m ki [DNaseI] .
(
site. As is evident from (1) presented and discussed.
MATERIALS AND METHODS
The preparation of the 139-base-pair restriction fragment obtained by cleavage of pBR-322 DNA using Hind III and Nci I was as previously described (18) . The fragment was end-labeled at position 33 (referenced to the standard numbering system of pBR-322 DNA) using a[32P]-dATP and reverse transcriptase.
Establishment of sequence was earlier described (18 The footprinting experiments were conducted as previously described (18 Analysis of the autoradiographic data was by linear scanning microdensitometry (15, 16) . From the autoradiographic data, a file consisting of a peak's number, corresponding to the genomic numbering system for pBR-322 DNA, and its cross-sectional area was created. The concentration of an oligomer was plotted as a function of drug concentration for each DNase I cleavage site in the region 48-110 of the fragment. These "footprinting plots" along with the summed band areas for all oligomers produced in a given digest formed the basis of the analysis. In the region 48-'110 on the fragment, single nucleotide resolution was observed. Differences due to errors in gel loading and digest periods were small, <10% (16) . higher site numbers. Since cleavage at any site is measurable only if there is no cutting between the site and the labeled end of the fragment, multiple cuts on a fragment would lead to lower intensities at higher site numbers.
However, since we are in the "2single-hit" regime, multiple cuts are unimportant.
The ratio of drug-blocked sites to free sites on the restriction fragment, associated with the initial loading events, was 0.27 for netropsin and 0.39 for actinomycin D. The sum of the concentrations of all oligoners produced in a given digest, as determined by microdensitometry, was constant over the concentration ranges studied for both drugs.
DISCUSSION
In the drug-DNA footprinting experiment, the drug may influence the cleavage rate by blocking the enzyme from cleaving at certain sites (16, 17) , altering DNA structure away from the sites of binding (19, 20) , or causing redistribution of the enzyme to regions where no drug binding is occurring.
Alteration of DNA structure can either increase or decrease the cleavage rate constant at a site, kj, so both inhibitions and enhancements in rates can be expected. Furthermore, the changes should differ markedly from one site to the next, and not always extend over the length of DNA expected for a drug binding site.
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The redistribution of enzyme should lead to increases in the rate of cleavage associated with all sites not involved in binding. If the total amount of cleavage on the fragment remains constant as drug loading occurs, as is the case for both the netropsin and actinomycin D footprinting experiments reported here, the amount of enzyme on the fragment is also constant. Thus, drug binding shifts enzyme to unblocked sites, increasing [DNase I]i at these sites. This mechanism predicts that all unblocked sites will exhibit the same fractional enhancement, the magnitude of which is related to the fraction of the total number of enzyme cleavage sites which are blocked by drug.
The footprinting results for both netropsin and actinomycin D show no significant decreases in cleavage rates at sites where no drug binding is occurring. Furthermore, the enhancements are relatively constant along the sequence, the exceptions being for sites immediately adjacent to drug-binding sites, Figure 4 . This suggests that most of the enhancements are not due to drug-induced structural changes, but rather are caused by a redistribution of enzyme over the fragment as sites load with drug. A check on this is provided by the magnitude of the enhancements. printing studies involving other cleaving agents will be necessary in order to establish the presence of altered structure at these sites.
The redistribution mechanism has important consequences for quantitative footprinting experiments leading to the evaluation of binding constants from footprinting data. The footprinting plots associated with a binding site must be corrected for the redistribution effect in order to obtain a valid isotherm for the site. If the ratio of blocked to free cutting sites is small, the correction will be negligible and the resulting footprinting plots can be directly used to determine the occupancy of the site. This situation most readily obtains in DNA-protein footprinting experiments, where, due to high binding specificity, only a small fraction of the total DNA present may be blocked from cleavage (21, 22) . However, if the fragment bearing the protein binding site is short, the fraction of protein bound sites to free sites will be significant. In this case accurate quantitative studies will require correction for redistribution effects. On the other hand, since drugs and other small ligands exhibit low binding specifities the ratio of blocked to free sites is generally large. In this case, the footprinting plots must be corrected for redistribution in order to obtain valid isotherms for the various binding sites present in the system.
Although the netropsin-DNA interaction has been analyzed using quantitative footprinting methods, and drug binding constants as a function of sequence determined (16, 17) , actinomycin D has not been studied in this way.
However, from the slope data presented in Table I and shown in Figure 4 , the strong binding sites for the drug are the sequences: 5'43', TGCT (62-65); CGCA (68-71); TGCG (100-103) and CGCT (102-105), all of which contains the dinucleotide sequence GC. This result is consistent with earlier footprinting studies (3) (4) (5) 7) and the large amount of physicochemical data collected on the antibiotic (12) (13) (14) indicating that the preferred site is GC. Interestingly, the sequence, GGCA (76-79), which also contains the dinucleotide GC, is only a weak binding site, Figures 2 and 3 . Although further study will be necessary, the stacking energy associated with the purine-purine sequence, GG, which precedes the intercalation site, may be the reason why binding at the adjacent GC site is discouraged.
